A strategy through investments? Why China's ‘Silk Road' plan has spelt unease for India, US, Russia

May 12, 2017

Beijing, May 12: In a mountain valley in Kashmir, plans are underway for Chinese engineers guarded by Pakistani forces to expand the lofty Karakoram Highway in a project that is stirring diplomatic friction with India.

china

The work is part of a sprawling Chinese initiative to build a “new Silk Road” of ports, railways and roads to expand trade in a vast arc of countries across Asia, Africa and Europe. The Asian Development Bank says the region, home to 60%?of the world's people, needs more than $26 trillion of such investment by 2030 to keep economies growing.

The initiative is in many ways natural for China, the world's biggest trader. But governments from Washington to Moscow to New Delhi worry Beijing also is trying to build its own political influence and erode theirs.

Others worry China might undermine human rights, environmental and other standards for lending or leave poor countries burdened with debt.

India is unhappy that Chinese state-owned companies are working in the Pakistani-occupied Kashmir. Indian leaders see that as an endorsement of Pakistani control.

“We have some serious reservations about it, because of sovereignty issues,” said India's finance and defence minister, Arun Jaitley, at an Asian Development Bank meeting this month in Yokohama, Japan. China has tried previously to mollify Indian anxiety by saying in January its highway work “targets no third country.”

China's new Silk Road initiative is ramping up as President Donald Trump focuses on domestic issues, downplaying foreign affairs.

American officials say Washington wants to work with China on infrastructure. But some diplomats and political analysts say Beijing is trying to create a political and economic network centered on China, push the United States out of the region and rewrite rules on trade and security.

At a Senate hearing in Washington on Thursday on global threats, Dan Coats, the US director of national intelligence, identified the Silk Road strategy as part of a pattern of “aggressive” Chinese investments and other actions around the world.

“They clearly have a strategy, through their investments,” Coats said. “You name a part of the world, the Chinese are probably there, looking to put investments in.” The Silk Road process, he said, is “a different way to address nations that they've had difficulty connecting with.”

William A Callahan, an international relations specialist at the London School of Economics, said China is trying to change the way the political structure of the region works.

“We will have to see whether it can achieve this,” he said.

Trump's decision to pull out of the proposed 12-nation Trans-Pacific Partnership deprives China's neighbours of a tool they hoped would counter its rising influence, said Max Baucus, the US ambassador to Beijing until January. Baucus called the move a “large geopolitical mistake.”

“Southeast Asian countries would tell me ‘We want you, we want the TPP, then we can balance China with the United States. But when you're not there, there is a void that China's going to fill,'“ Baucus told The Associated Press.

Dubbed “One Belt, One Road” after ancient trade routes through the Indian Ocean and Central Asia, the initiative is Chinese President Xi Jinping's signature project.

Details such as financing are vague. But since Xi announced it in 2013, Beijing has launched dozens of projects from railways in Tajikistan, Thailand and Kenya to power plants in Vietnam and Kyrgyzstan, financed mostly by Chinese loans.

Countries including Pakistan and Afghanistan welcome it as a path out of poverty. India, Indonesia and others want investment but are wary of Chinese strategic ambitions, especially after Beijing started building artificial islands to enforce its claim to most of the South China Sea, a busy trade route.

Indonesia's political elite have a “fear of regional hegemony” by China, said Christine Tjhin, senior researcher at the Center for Strategic and International Studies in Jakarta.

Moscow worries Beijing is diluting Russian influence in Central Asia by linking Uzbekistan and other countries more closely to China's more dynamic economy.

Russian President Vladimir Putin responded last June by proposing a “Great Eurasia Project,” with Beijing leading on economics and Moscow on politics and security.

“This vision enables the Kremlin to maintain an appearance that it retains the political initiative in its neighbourhood,” Marcin Kaczmarski and Witold Rodkiewicz said in a report for the Center for Eastern Studies, a Warsaw think tank.

Perhaps trying to defuse unease, China has invited governments to a two-day forum starting Sunday and led by Xi to “brainstorm on interconnected development.”

Leaders from 28 countries including Putin are due to attend, but none from major Western countries.

“One Belt, One Road” is the biggest of a series of initiatives launched by Beijing in the past decade in pursuit of global influence to match its economic success.

Starting in 2004, the communist government opened Confucius Institutes with universities in Asia, Europe and the Americas to teach Chinese language and culture. After the 2008 global crisis, Beijing lobbied successfully for more voting rights in the US- and European-dominated World Bank and International Monetary Fund.

Chinese officials reject suggestions “One Belt, One Road” is a power play by Beijing.

“The Chinese government has never wished to control any other country's government,” a cabinet official, Ou Xiaoli, told The AP. “We feel in contacts between countries, we need to talk about studying benefits, studying mutual profit.”

The bulk of Chinese financing is to be loans, which Ou said will be mostly on commercial terms based on “market principles.” That might add to debt burdens in countries where dealing with Beijing can be politically sensitive.

Sri Lanka's former president suffered a surprise election defeat in 2015 after his challenger criticised him for running up an estimated $5 billion in debt to China. Villagers protesting a $1.2 billion Chinese port project there violently clashed with government supporters as recently as January.

China often is the only entity willing to finance big projects in poor countries. That gives Beijing leverage to require use of Chinese builders and technology.

The state-run China Development Bank announced in 2015 it had set aside $890 billion for more than 900 “One Belt, One Road” projects across 60 countries in gas, minerals, power, telecoms, infrastructure and farming. This year, the government's Export-Import Bank of China said it would finance 1,000 projects in 49 countries.

Beijing will provide only part of the financing and wants projects to attract private investors, Ou said.

“We must consider economic viability,” he said.

China is far from alone in promoting infrastructure investment.

Japan has given Southeast Asian governments tens of billions of dollars in grants or low-interest loans. The Asian Development Bank lent $32 billion last year.

South Korea launched its “Eurasia Initiative” in 2013 to develop rail, trade and energy links across the two Koreas and Russia to Europe. That stalled last year due to trade sanctions imposed on North Korea over its nuclear weapons development.

US allies Britain, South Korea and Australia signed on as founding members of the Chinese-led Asian Infrastructure Investment Bank, launched in 2015 to finance roads, ports and other projects. The US and Japan have so far stayed away.

Ou said AIIB will operate separately from “One Belt, One Road” and any loans made by the bank will be decided independently.

In Pakistan, the proposed $1.3 billion effort to expand the Karakoram Highway is part of the China-Pakistan Economic Corridor, which involves dozens of projects including power plants, roads and railways spanning the length of the country. It links China's far western region of Xinjiang with the Chinese-built port of Gwadar on the Indian Ocean.

“It threatens no one. It benefits all, most of all the common man who shall see a boom in jobs and businesses,” Pakistani Prime Minister Nawaz Sharif said in April.

TRADE CONCERNS

“One Belt, One Road” could help China's exporters by encouraging countries to adopt its industrial standards for railways and other products, locking buyers into sticking with them for repairs or additional technologies. China's premier has cited the promoting of Chinese standards abroad as one of Beijing's goals.

This has some countries in the region concerned about China's dominance, Baucus said. “‘We're going to have to bow to their standards and if they're Chinese standards, then Chinese companies are going to have an advantage over our companies in our country,'“ the former US ambassador described officials as telling him. “They're very concerned.”

Chinese rail technology is poised to make inroads into the European Union with a plan for state-owned companies to build a high-speed line from Budapest, capital of EU member Hungary, to Belgrade in neighboring Serbia.

The $2.9 billion project, financed by Beijing, faces obstacles after EU officials said they will look into whether Hungary broke trade bloc rules by agreeing to the Chinese deal without competitive bidding.

In Pakistan, officials say much of the Chinese money for power projects is investment, not loans. They have given few details, raising questions about whether other projects can pay for themselves.

“China is giving most contracts for energy projects to its own companies without even consulting Pakistan,” said Azeem Khalid, a lecturer at the Commission on Science and Technology for Sustainable Development in the South, a non-government group in Islamabad. “I feel that our several generations will have to repay these Chinese loans for decades.”

In Indonesia, the Chinese effort could fit with President Joko “Jokowi” Widodo's “Maritime Axis Policy” to transform the country into a sea power. China muscled aside Japan in 2015 to win a contract to build a $5.2 billion high-speed rail line from the capital, Jakarta, to the city of Bandung.

But Indonesian leaders also are wary of a backlash in a country where resentment of ethnic Chinese billionaires simmers.

“The Jokowi government must balance its desire for capital and expertise with a need to guard against a populist, anti-Chinese backlash,” said Hugo Brennan, an analyst at political risk firm Verisk Maplecroft.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 9,2020

Wuhan, Jun 9: China on Tuesday dismissed as "incredibly ridiculous" a Harvard study, which pointed to a surge in traffic outside Wuhan hospitals from August 2019 suggesting that the coronavirus hit the area far earlier than reported.

A whitepaper on coronavirus released by China on Sunday said the virus was first noticed on December 17 and Chinese virologists confirmed human-to-human transmission on January 19, prompting authorities to impose lockdown of Wuhan from January 23.

US President Donald Trump and leaders of several countries have accused China of not being transparent in reporting the deadly disease, leading to huge human casualties and economic crisis across the world.

The new study by Harvard researchers says satellite images show an increase in traffic outside five hospitals in Wuhan from late August to December.

The traffic spike coincided with a rise in online searches for information on symptoms like "cough" and "diarrhoea".

China said the study was "ridiculous" and based on "superficial" information, BBC reported.

It is believed that the virus first appeared in China some time in November. Authorities reported a cluster of pneumonia cases with an unknown cause to the World Health Organization (WHO) on December 31.

"Clearly, there was some level of social disruption taking place well before what was previously identified as the start of the novel coronavirus pandemic," Dr John Brownstein, who led the research, told ABC news.

The study has not been peer-reviewed.

The researchers examined commercial satellite data from outside five Wuhan hospitals, comparing data from late summer and autumn 2018 to the same time period in 2019.

In one case, researchers counted 171 cars parked at one of Wuhan''s largest hospitals, Tianyou Hospital, in October 2018.

Satellite data from the same time in 2019 showed 285 vehicles in the same place, an increase of 67 per cent.

A surge in online searches for words associated with the symptoms of coronavirus on the Chinese search engine Baidu seemed to emerge at the same time.

"This is all about a growing body of information pointing to something taking place in Wuhan at the time," Dr Brownstein said.

"Many studies are still needed to fully uncover what took place and for people to really learn about how these disease outbreaks unfold and emerge in populations. So this is just another point of evidence," he said.

Asked for her reaction at the media briefing, Chinese Foreign Ministry spokeswoman Hua Chunying dismissed the findings as "incredibly ridiculous".

"I think it is ridiculous, incredibly ridiculous, to come up with this conclusion based on superficial observations such as traffic volume," she said.

"(I have) Not seen the research you mentioned. If the conclusion is drawn based on traffic volumes (and) other superficial observations, it won’t be a sound conclusion," she said and referred to the allegations about the COVID-19 originating from the Wuhan Institute of Virology (WIV) by Trump.

"That allegation was proved to be wrong," she said.

When pointed out that China says it respects science based inquiry and Harvard is one of the top universities in the world, Hua said, "on the origin of virus there are lot of conspiracy theories against China”.

"That is very unfair. At the moment, the pressing task is to enhance coordination to contain the spread of the virus. Someday, I am sure the truth will be out. China deserves a fair and objective evaluation," she said and referred to the whitepaper released by the Chinese government detailing evolution of coronavirus in Wuhan and how Beijing handled the situation.

Recently, the World Health Assembly (WHA), the decision-making body of Geneva-based World Health Organization (WHO), passed a resolution to probe the origin of the virus. China also backed the resolution.

As of Monday, the overall confirmed cases on the mainland had reached 83,043, including 58 patients who were still being treated, with no one in severe condition, China’s National Health Commission, (NHC) said.

Altogether 78,351 people had been discharged after recovery and 4,634 people had died of the disease, it said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 20,2020

Washington, May 20: The United States recorded another 1,536 coronavirus deaths over the past 24 hours, the Johns Hopkins University tracker said.

That figure, tallied as of 8:30 pm (0030 GMT), raises to 91,845 the total number of COVID-19 deaths in the US.

The US tops the global rankings both for the highest death toll and the highest number of infections, with more than 1.5 million cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 4,2020

Jun 4: A malaria drug President Donald Trump took to try to prevent COVID-19 proved ineffective for that in the first large, high-quality study to test it in people in close contact with someone with the disease.

Results published Wednesday by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the coronavirus.

The drug did not seem to cause serious harm, though -- about 40% on it had side effects, mostly mild stomach problems.

 “We were disappointed. We would have liked for this to work,” said the study leader, Dr. David Boulware, an infectious disease specialist at the University of Minnesota.

“But our objective was to answer the question and to conduct a high-quality study,” because the evidence on the drug so far has been inconclusive, he said.

Hydroxychloroquine and a similar drug, chloroquine, have been the subject of much debate since Trump started promoting them in March.

Hydroxychloroquine has long been used for malaria, lupus, and rheumatoid arthritis, but no large studies have shown it or chloroquine to be safe or effective for much sicker patients with coronavirus, and some studies have suggested the drugs may do harm.

Trump took a two-week course of hydroxychloroquine, along with zinc and Vitamin D, after two staffers tested positive for COVID-19, and had no ill effects, according to results of his latest physical released by his doctor Wednesday.

Federal regulators have warned against hydroxychloroquine's use except in hospitals and formal studies because of the risk of side effects, especially heart rhythm problems.

Boulware's study involved 821 people in the United States and Canada living with someone diagnosed with COVID-19 or at high risk of getting it because of their job -- doctors, nurses, ambulance workers who had significant exposure to a sick patient while not wearing full protective gear.

They were randomly assigned to get either the nutrient folate as a placebo or hydroxychloroquine for five days, starting within four days of their exposure. Neither they nor others involved in the research knew who was getting which pills.

After 14 days in the study, 12 per cent on the drug developed COVID-19 symptoms versus 14 per cent in the placebo group, but the difference is so small it could have occurred by chance, Boulware said.

“There's basically no effect. It does not prevent infection,” he said of the drug. Even if it were to give some slim advantage, “we'd want a much larger effect” to justify its use and risk of side effects for preventing illness, he said.

Results were no different among a subgroup of participants who were taking zinc or vitamin C, which some people believe might help make hydroxychloroquine more effective or fight the coronavirus.

There are some big caveats: The study enrolled people through the Internet and social media, relying on them to report their own symptoms rather than having them tracked in a formal way by doctors.

Participants were not all tested for the coronavirus but were diagnosed as COVID-19 cases based on symptoms in many cases. And not all took their medicines as directed.

The results “are more provocative than definitive,” and the drug may yet have prevention benefits if tried sooner or in a different way, Dr. Myron Cohen of the University of North Carolina at Chapel Hill wrote in a commentary in the journal.

Others were glad to see a study that had a comparison group and good scientific methods after so many weaker reports on hydroxychloroquine.

“This fits with everything else we've seen so far which suggests that it's not beneficial," said Dr. Peter Bach, director of a health policy center at Memorial Sloan Kettering Cancer Center in New York.

This study was in younger relatively healthy people, but the results “would make me very discouraged about trying to use this in older people” who are most vulnerable to serious illness from the coronavirus, Bach said.

“If it does work, it doesn't work very well.” Dr. Dan Culver, a lung specialist at the Cleveland Clinic, said there's still a chance that giving the drug sooner than four days after someone's exposure to the virus may help prevent illness.

But the study “takes 'home run' off the table” as far as hopes for the drug, he said.

The study was mostly funded by David Baszucki, founder of Roblox, a California-based game software company, and other private donors and the Minnesota university.

Boulware also is leading a study testing hydroxychloroquine for treating COVID-19. The study is finished and results are being analyzed now.

On Tuesday, the journal Lancet posted an “expression of concern” about a study it published earlier this month of nearly 15,000 COVID-19 patients on the malaria drugs that tied their use to a higher risk of dying in the hospital or developing a heartbeat problem.

Scientists have raised serious questions about the database used for that study, and its authors have launched an independent audit.

That work had a big impact: the World Health Organization suspended use of hydroxychloroquine in a study it is leading, and French officials stopped the drug's use in hospitals. On Wednesday, the WHO said experts who reviewed safety information decided that its study could resume.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.